Semaglutide could benefit millions of Americans with obesity, heart disease
The anti-obesity drug has the potential to reduce the risk of heart attacks and other heart-related conditions among 6.6 million Americans, a Yale study finds.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news
More News: Cardiology | Eating Disorders & Weight Management | Health | Heart | Heart Disease | Obesity | Science | Study | Universities & Medical Training | Yale